ASTM-D4774 › Standard Specification for User Applied Drug Labels in Anesthesiology (Withdrawn 2022)
The following bibliographic material is provided to assist you with your purchasing decision:
This specification covers the size, color and pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer. The size and background color requirements of drug labels are presented in details. The type and color requirements of printing for drug labels are presented in details.
Scope
1.1 This specification covers the size, color, pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer.
FIG. 1 Standard Background Colors for User Applied Syringe Drug Labels
FIG. 2 Label for an Antagonist Drug
FIG. 3 Reversed Plate Printing Used to Identify "SUCCINYLcholine," "EPINEPHrine," and Beta Blockers, "ESMOlol," "LABATolol," and "METOprolol"
FIG. 4 Optional Printing
FIG. 5 Drug Name and Dosage
FIG. 6 Alternative Label Showing Concentration in Percent and mg/mL
1.2 The values stated in SI units are to be regarded as the recommended values. The use of inch-pound system values, not being exact equivalents, may result in nonconformance with the standard.
1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.4 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Significance and Use
5.1 The objective of this specification is to facilitate identification of drugs in syringes filled by the user. The use of colors is intended only as an aid in identification of drug groups and does not absolve the user from the duty to read the label to correctly identify the drug prior to use.
5.2 The user may alternatively use black and white labels rather than these colored labels.
Keywords
anesthesiology; drug labels; label requirements;
To find similar documents by ASTM Volume:
15.10 (Packaging; Flexible Barrier Packaging)
To find similar documents by classification:
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Customers who bought this document also bought:
ASQ-Z1.4Sampling Procedures and Tables for Inspection by Attributes - Paper Format - Reaffirmed in 2018
ISO-10993-1
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
ISO-9626
Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods
Document Number
ASTM-D4774-11(2017)
Revision Level
2011 R17 EDITION
Status
Cancelled
Modification Type
Withdrawn
Publication Date
Dec. 15, 2017
Document Type
Specification
Page Count
3 pages
Committee Number
F02.50